Sponsor pipeline

Cellbion Co., Ltd. clinical trial pipeline

Get alerts when Cellbion Co., Ltd.'s trials change

2 active trials 1 recruiting 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT05547061 A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and… Prostate Cancer Active, Not Recruiting 2024-12-11
Phase 1
NCT07244393 Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant… Metastatic Castration-resistant Prostate Cancer (mCRPC) Recruiting 2026-10-07

Disease areas by active trials

Prostate Cancer (2)

Get alerts when Cellbion Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free